Duloxetine hydrochlorideProduct ingredient for Duloxetine

Duloxetine is a dual serotonin and norepinephrine reuptake inhibitor.^Label It was originally discovered in 1993 and developed by Eli Lilly and Company as LY248686.¹⁵ Duloxetine first received approval from the FDA in August, 2004 as Cymbalta for the treatment of Major Depressive Disorder.²⁰ It has since received approval for a variety of indications including the treatment of neuropathic pain, Generalized Anxiety disorder, osteoarthritis, and stress incontinence. Duloxetine continues to be investigated for the treatment of pain in cancer, surgery, and more.